Po-HongLiuMDMPH

Gastroenterology • Federal Way, WA

Clinical Informatics

Stuart Po-Hong Liu, MD, MPH

Join to view full profile

Dr. Liu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Liu's full profile

Already have an account?

Office
33915 1st Way S
Ste 200
Federal Way, WA 98003
Phone+1 253-838-9839

Fax+1 253-661-9077

Summary

Dr. Po-Hong (Stuart) Liu, MD, MPH, is a dedicated gastroenterologist based in Federal Way, Washington. He is also a clinical investigator with a focus on gastrointestinal and liver diseases. Dr. Liu received his training in internal medicine and gastroenterology at Taipei Veterans General Hospital in Taiwan and UT Southwestern Medical Center in Dallas, Texas. Additionally, he holds an MPH degree from Harvard T.H. Chan School of Public Health, specializing in biostatistics and epidemiology.

Dr. Liu has an extensive publication record on topics such as the management and prognosis of hepatocellular carcinoma, gastrointestinal epidemiology, inflammatory bowel disease, and colorectal cancer. His contributions to the field have earned him several national and international junior investigator awards.

Beyond his medical career, Dr. Liu enjoys exploring history, technology, and the outdoors. He is an avid fan of cycling races, loves traveling, spending time with squirrels, and is passionate about transitional justice.

Education & Training

University of Texas Southwestern Medical CenterFellowship, Gastroenterology, 2020 - 2024
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2018 - 2020
Harvard School of Public HealthMPH, Quantitative Methods (Biostatistics and Epidemiology), 2017
National Yang Ming University Medical CollegeClass of 2008

Certifications & Licensure

TX State Medical License 2022 - 2026
WA State Medical License 2024 - 2026
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Full Bursaries for Young Investigator European Association for the Study of the Liver, 2016
Professor Juei-Low Sung Research Award 2016
Young Investigator Award, First Prize Taipei Veterans General Hospital, 2016
Young Investigator Award, Second Prize Asian-Pacific Digestive Disease Week, 2015
Best Intern Award Taichung Veterans General Hospital, 2007
Join now to see all

Publications & Presentations

PubMed

1 citations
Comparing SEER and NCDB: a case study using colorectal cancer.
Po-Hong Liu, Sandi L Pruitt, Amit G Singal, Caitlin C Murphy
Cancer Causes & Control. 2024-11-01
Evolving trends in CT colonography: A 10-year analysis of use and associated factors.
Ali Abbas, Po-Hong Liu, Amit G Singal, Cecelia Brewington
Clinical Imaging. 2024-09-01
Screening Implications for Distribution of Colorectal Cancer Subsite by Age and Role of Flexible Sigmoidoscopy.
Gloria Lin, David M Hein, Po-Hong Liu, Amit G Singal, Nina N Sanford
Cancers. 2024-03-10

Journal Articles

Detecting microvascular invasion in HCC with contrast-enhanced MRI: Is it a good idea?
Huo TI, Liu PH, Hsu CY, J Hepatol, 1/1/2018
Prognostic performance of ten liver function models in patients with hepatocellular carcinoma undergoing radiofrequency ablation
Ho SY, Liu PH, Hsu CY, Chiou YY, Su CW, Lee YH, Huang YH, Lee FY. Hou MC, Huo TI, Scientific Reports, 1/1/2018
Performance status in patients with HCC: New kid on the block
Huo TI, Hsu CY, Liu PH, J Hepatol, 1/1/2017
Prognostic impact of diabetes mellitus on hepatocellular carcinoma: Special emphasis from the BCLC perspective
Su YW*, Liu PH*, Hsu CY, Lee YH, Hsia CY, Ho SY, Hou MC, Chen HS, Huo TI, PLoS One, 1/1/2017
Impact of tumor burden on prognostic prediction for patients with terminal stage hepatocellular carcinoma: A nomogram study
Hsu CY, Liu PH, Ho SY, Huang YH, Lee YH, Chiou YY, Hsieh TH, Fang T, Tsai YJ, Hou MC, Huo TI, PLoS One, 1/1/2017
A New Treatment-integrated Prognostic Nomogram of the Barcelona Clinic Liver Cancer System for Hepatocellular Carcinoma
Hsu CY, Liu PH, Hsia CY, Lee YH, Nagaria TS, Lee RC, Ho SY, Hou MC, Huo TI., Scientific Reports, 1/1/2017
Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization
Ho SY, Liu PH, Hsu CY, Hsia CY, Lee YH, Lee RC, Huang YH, Lee FY, Hou MC, Tsai YJ, Huo TI., PLoS One, 1/1/2017
Evaluation of the Current Guidelines for Resection of hepatocellular carcinoma Using the Appraisal of Guidelines Research and Evaluation II Instrument
Gavriilidis P, Roberts KJ, Askari A, Sutcliffe RP, Liu PH, Hidalgo E, Compagnon P, Lim C, Azoulay D, J Hepatol, 1/1/2017
Treating very early-stage HCC: Have we found the Holy Grail?
Liu PH, Huo TI, Ann Surg, 1/1/2017
Ablation for hepatocellular carcinoma: Where do we stand?
Liu PH, Huo TI, Ann Surg, 1/1/2017
ALBI and PALBI Grade Predict Survival for HCC across Treatment Modalities and BCLC Stages in the MELD Era
Liu PH, Hsu CY, Hsia CY, Lee YH, Chiou YY, Huang YH, Lee FY, Lin HC, Hou MC, Huo TI., J Gastro Hepatol, 1/1/2017
Comment on “Transarterial chemoembolization of hepatocellular carcinoma: impact of liver function and vascular invasion”
Huo TI, Liu PH, Hsu CY., Br J Cancer, 1/1/2017
ALBI score as a novel tool in staging and treatment planning for hepatocellular carcinoma: Is it sufficient?
Huo TI, Liu PH, Hsu CY., Liver Cancer, 1/1/2017
Adherence to a healthy lifestyle is associated with a lower risk of diverticulitis among men
Liu PH, Cao Y, Keeley BR, Tam I, Wu K, Strate LL, Giovannucci EL, Chan AT., Am J Gastroenterol, 1/1/2017
Reply to “”Hepatocellular carcinoma scoring and staging systems Do we need new tools?”
Liu PH, Huo TI, J Hepatol, 1/1/2016
Utility of prognostic scoring systems in management of hepatocellular carcinoma
Liu PH, Huo TI, Eur J Cancer, 1/1/2016
Nomogram of the Barcelona Clinic Liver Cancer System for Individual Prognostic Prediction In Hepatocellular Carcinoma
Hsu CY, Liu PH, Hsia CY, Lee YH, Juboori AA, Lee RC, Lin HC, Huo TI., Liver International, 1/1/2016
Surgical Resection is Better than Transarterial Chemoembolization for Patients with Hepatocellular Carcinoma Beyond the Milan Criteria: A Prognostic Nomogram Study
Hsu CY, Liu PH, Hsia CY, Lee YH, Nagaria TS, Lee RC, Lin HC, Huo TI, Ann Surg Oncol, 1/1/2016
Prognosis of hepatocellular carcinoma: Assessment of eleven staging systems
Liu PH, Hsu CY, Hsia CY, Lee YH, Su CW, Huang YH, Lee FY, Lin HC, Huo TI, J Hepatol, 1/1/2016
Liu PH, Hsu CY, Hsia CY, Lee YH, Huang YH, Chiou YY, Lin HC, Huo TI., Ann Surg, 1/1/2016
Proposal and Validation of a New Model to Estimate Survival for Hepatocellular Carcinoma Patients
Liu PH, Hsu CY, Hsia CY, Lee YH, Huang YH, Su CW, Lee FY, Lin HC, Huo TI., Eur J Cancer, 1/1/2016
Solitary Large Hepatocellular Carcinoma: Staging and Treatment Strategy
Liu PH, Su CW, Hsu CY, Hsia CY, Lee YH, Huang YH, Lee RC, Lin HC, Huo TI., PLoS ONE, 1/1/2016
Impact of renal insufficiency on patients with hepatocellular carcinoma undergoing radiofrequency ablation
Chen CF, Liu PH, Lee YH, Tsai YJ, Hsu CY, Huang YH, Chiou YY, Huo TI., J Gastroenterol Hepatol, 1/1/2015
Inadvertent submucosal esophageal tunnel complicating ERCP
Liu PH, Yang TC, Chen PH, Chen CC, Hou MC, Endoscopy, 1/1/2015
Surgery for advanced hepatocellular carcinoma: Time to take action
Liu PH, Huo TI, J Surg Oncol, 1/1/2015
Join now to see all

Abstracts/Posters

Adherence to a Healthy Lifestyle Reduces Risks of Diverticulitis among Men.
Liu PH, Digestive Disease Week, Chicago, 1/1/2017
ALBI and PALBI Grade Predict Survival for HCC across Treatment Modalities and BCLC Stages in the MELD Era
Liu PH, Liver Meeting 2016, American Association for the Study of Liver Diseases, Boston, 1/1/2016
Hong Kong Liver Cancer staging system is associated with better performance for hepatocellular carcinoma: Special emphasis on viral etiology.
Liu PH, Liver Meeting 2015, American Association for the Study of Liver Diseases, San Francisco, 1/1/2015
Liu PH, International Liver Congress of the European Association for the Study of the Liver, Vienna, Austria, 1/1/2015
Join now to see all

Lectures

Obesity and Risk of Young-Onset Colorectal Cancer
Washington D.C. - 1/1/2018
Proposal and Validation of a New Model to Estimate Survival for Hepatocellular Carcinoma Patients.
Barcelona, Spain - 1/1/2016
When to perform surgical resection or radiofrequency ablation for early hepatocellular carcinoma? A nomogram-guided treatment strategy.
Taipei, Taiwan - 1/1/2015
Survival advantage of radiofrequency ablation over transarterial chemoembolization for patients with hepatocellular carcinoma and good performance status within the Mi...
Taipei, Taiwan - 1/1/2014
Join now to see all